❌

Mehr »

Ad hoc-Mitteilungen:

Montag, 05.05.2025 - Börsentäglich über 12.000 News

Rebranding vollzogen - Copper Giant startet durch mit Monster-Bohrungen in Mocoa!

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche

Aktien»Nachrichten»TAKEDA PHARMACEUTICAL AKTIE»Novavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In Japan

Branche

Chemie

Aktienmarkt

NIKKEI-225
Singapur

1-Jahres-Chart

TAKEDA PHARMACEUTICAL CO LTD Chart 1 Jahr

5-Tage-Chart

Realtime	Geld	Brief	Zeit
	26,790	27,040	20:50
	26,640	27,000	20:47

AFX News

05.05.2025 14:42 Uhr

234 Leser

Artikel bewerten:

(1)

Novavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In Japan

TOKYO (dpa-AFX) - Novavax, Inc. (NVAX) said it has updated the terms of the collaboration and licensing agreement with Takeda. The company noted that the improved financial terms of the amended agreement for the development, manufacturing and commercialization of Nuvaxovid in Japan include an upfront payment, payment related to the 2024/2025 season, annual milestones associated with regulatory approvals and royalties on net sales earned every season moving forward.

John Jacobs, President and CEO, Novavax, said: 'This partnership further validates our cutting-edge technology platform and proprietary Matrix-M adjuvant and our efforts to become a partner of choice.'

For More Such Health News, visit rttnews.com.

Copyright(c) 2025 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

Zeit	Aktuelle Nachrichten
15:25	NOVAVAX INC - 8-K, Current Report
15:24	Novavax reports revised terms for Takeda agreement for Nuvaxovid in Japan
14:42	Novavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In Japan	TOKYO (dpa-AFX) - Novavax, Inc. (NVAX) said it has updated the terms of the collaboration and licensing agreement with Takeda. The company noted that the improved financial terms of the amended... ► Artikel lesen
14:00	Novavax, Inc.: Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in Japan	Improved financial terms for Novavax and streamlined operations will help both companies better meet the needs of the Japanese market Nuvaxovid®, a protein-based... ► Artikel lesen
13:35	Novavax to Report First-Quarter Earnings: Is a Beat in Store?

Zeit	Aktuelle Nachrichten
15:24	Novavax reports revised terms for Takeda agreement for Nuvaxovid in Japan
14:42	Novavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In Japan	TOKYO (dpa-AFX) - Novavax, Inc. (NVAX) said it has updated the terms of the collaboration and licensing agreement with Takeda. The company noted that the improved financial terms of the amended... ► Artikel lesen
14:00	Novavax, Inc.: Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in Japan	Improved financial terms for Novavax and streamlined operations will help both companies better meet the needs of the Japanese market Nuvaxovid®, a protein-based... ► Artikel lesen
Di	Takeda receives CHMP recommendation for Adcetris in Hodgkin lymphoma
23.04.	Takeda Pharmaceutical: Neue Umsatzprognosen und Analystenerwartungen

5-Tage-Chart
NOVAVAX

Unternehmen / Aktien	Kurs	%
NOVAVAX INC	5,679	+0,07 %
TAKEDA PHARMACEUTICAL CO LTD	26,760	-1,80 %

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

TAKEDA PHARMACEUTICAL CO LTD

Novavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In Japan